{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T01:14:36Z","timestamp":1780103676361,"version":"3.54.0"},"reference-count":84,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,23]],"date-time":"2020-12-23T00:00:00Z","timestamp":1608681600000},"content-version":"am","delay-in-days":357,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ibroneuroscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.neuroscience.2019.11.020","type":"journal-article","created":{"date-parts":[[2019,11,26]],"date-time":"2019-11-26T11:27:18Z","timestamp":1574767638000},"page":"280-300","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Screening for Efficacious Anticonvulsants and Neuroprotectants in Delayed Treatment Models of Organophosphate-induced Status Epilepticus"],"prefix":"10.1016","volume":"425","author":[{"given":"Bryan S.","family":"Barker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay","family":"Spampanato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilary S.","family":"McCarren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Smolik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecelia E.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eden N.","family":"Hornung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5692-0170","authenticated-orcid":false,"given":"David T.","family":"Yeung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. Edward","family":"Dudek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John H.","family":"McDonough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2019.11.020_b0005","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ejphar.2016.07.048","article-title":"Evaluation of neuroprotective, anticonvulsant, sedative and anxiolytic activity of citicoline in rats","volume":"789","author":"Abdolmaleki","year":"2016","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2019.11.020_b0010","first-page":"22","article-title":"The synthetic neuroactive steroid SGE-516 reduces status epilepticus and neuronal cell death in a rat model of soman intoxication","volume":"68","author":"Althaus","year":"2017","journal-title":"E&B"},{"key":"10.1016\/j.neuroscience.2019.11.020_b0015","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.neuro.2010.05.014","article-title":"Higher susceptibility of the ventral versus the dorsal hippocampus and the posteroventral versus anterodorsal amygdala to soman-induced neuropathology","volume":"31","author":"Apland","year":"2010","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuroscience.2019.11.020_b0020","unstructured":"Associated Press (2018, December 15) Suspected food poisoning kills 11 at Indian temple ceremony. Retrieved July 26, 2019 from https:\/\/www.apnews.com\/dd1a31ec2bbc4e7faa6d277007bbf120."},{"key":"10.1016\/j.neuroscience.2019.11.020_b0025","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/WCO.0b013e32833735cf","article-title":"Neurosteroids and epilepsy","volume":"23","author":"Biagini","year":"2010","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.neuroscience.2019.11.020_b0030","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/00001199-200208000-00005","article-title":"Clinical use of cholinomimetic agents: a review","volume":"17","author":"Blount","year":"2002","journal-title":"J Head Trauma Rehabil"},{"key":"10.1016\/j.neuroscience.2019.11.020_b0035","doi-asserted-by":"crossref","first-page":"8602","DOI":"10.1523\/JNEUROSCI.0633-10.2010","article-title":"Disease-modifying effects of phenobarbital and the NKCC1 inhibitor bumetanide in the pilocarpine model of temporal lobe epilepsy","volume":"30","author":"Brandt","year":"2010","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2019.11.020_b0040","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/S0022-3565(24)36511-5","article-title":"Characterization of the anticonvulsant properties of ganaxolone (CCD 1042; 3alpha-hydroxy-3beta-methyl-5alpha-pregnan-20-one), a selective, high-affinity, steroid modulator of the gamma-aminobutyric acid(A) receptor","volume":"280","author":"Carter","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuroscience.2019.11.020_b0045","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.neuro.2012.03.011","article-title":"Organophosphate-induced brain damage: mechanisms, neuropsychiatric and neurological consequences, and potential therapeutic strategies","volume":"33","author":"Chen","year":"2012","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuroscience.2019.11.020_b0050","unstructured":"Cheng M (2018, March 12) UK says ex-spy poisoned with Soviet-developed nerve agent. Retrieved July 26, 2019 from https:\/\/www.apnews.com\/1a4c95b0e6af4d70b054c8030e177b47."},{"key":"10.1016\/j.neuroscience.2019.11.020_b0055","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1021\/acschemneuro.8b00148","article-title":"Nerve agents: what they are, how they work, how to counter them","volume":"9","author":"Costanzi","year":"2018","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.neuroscience.2019.11.020_b0060","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.3892\/mmr.2015.3611","article-title":"Chloroquine exerts neuroprotection following traumatic brain injury via suppression of inflammation and neuronal autophagic death","volume":"12","author":"Cui","year":"2015","journal-title":"Mol Med Rep"},{"issue":"Suppl 9","key":"10.1016\/j.neuroscience.2019.11.020_b0065","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/epi.12037","article-title":"Possible alterations in GABAA receptor signaling that underlie benzodiazepine-resistant seizures","volume":"53","author":"Deeb","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuroscience.2019.11.020_b0070","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1111\/j.1528-1167.2012.03654.x","article-title":"Bumetanide reduces seizure frequency in patients with temporal lobe epilepsy","volume":"54","author":"Eftekhari","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuroscience.2019.11.020_b0075","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2147\/ciia.2006.1.3.247","article-title":"Citicoline (Cognizin) in the treatment of cognitive impairment","volume":"1","author":"Fioravanti","year":"2006","journal-title":"Clin Interv Aging"},{"issue":"21","key":"10.1016\/j.neuroscience.2019.11.020_b0080","doi-asserted-by":"crossref","first-page":"5337","DOI":"10.1002\/chem.201805075","article-title":"Resurrection and Reactivation of Acetylcholinesterase and Butyrylcholinesterase","volume":"25","author":"Franjesevic","year":"2018","journal-title":"Chemistry"},{"key":"10.1016\/j.neuroscience.2019.11.020_b0085","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/00004691-199204010-00007","article-title":"Subcortical structures and pathways involved in convulsive seizure generation","volume":"9","author":"Gale","year":"1992","journal-title":"J Clin Neurophysiol"},{"key":"10.1016\/j.neuroscience.2019.11.020_b0090","unstructured":"Gardiner Harris HK (2013, October 22) Two Charged in School Lunch Poisoning Case in India. Retrieved July 26, 2019 from https:\/\/www.nytimes.com\/2013\/10\/23\/world\/asia\/two-charged-in-school-lunch-poisoning-case-in-india.html."},{"key":"10.1016\/j.neuroscience.2019.11.020_b0095","series-title":"The Rat Brain in Stereotaxic Coordinates 6th","author":"George Paxinos","year":"2007"},{"key":"10.1016\/j.neuroscience.2019.11.020_b0100","first-page":"13","article-title":"Status epilepticus, blood-brain barrier disruption, inflammation, and epileptogenesis","volume":"49","author":"Gorter","year":"2015","journal-title":"E&B"},{"key":"10.1016\/j.neuroscience.2019.11.020_b0105","unstructured":"Gregory Katz DK, Jill Lawless (2018, July 5) UK town faces new reality: Another nerve agent poisoning. Retrieved July 26, 2019 from https:\/\/apnews.com\/12a4c10e591f456da276d9c28fa1a5d2."},{"key":"10.1016\/j.neuroscience.2019.11.020_b0110","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0022-510X(90)90185-P","article-title":"Decreased brain pathology in organophosphate-exposed rhesus monkeys following benzodiazepine therapy","volume":"98","author":"Hayward","year":"1990","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neuroscience.2019.11.020_b0115","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/3190891","article-title":"Synthesis and storage stability of diisopropylfluorophosphate","author":"Heiss","year":"2016","journal-title":"J Chem"},{"key":"10.1016\/j.neuroscience.2019.11.020_b0120","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1111\/j.1471-4159.2011.07464.x","article-title":"Chloroquine inhibits glutamate-induced death of a neuronal cell line by reducing reactive oxygen species through sigma-1 receptor","volume":"119","author":"Hirata","year":"2011","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2019.11.020_b0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vascn.2019.02.006","article-title":"Validating a model of benzodiazepine refractory nerve agent-induced status epilepticus by evaluating the anticonvulsant and neuroprotective effects of scopolamine, memantine, and phenobarbital","volume":"97","author":"Jackson","year":"2019","journal-title":"J Pharmacol Toxicol Methods"},{"key":"10.1016\/j.neuroscience.2019.11.020_b0130","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/697305","article-title":"Anticonvulsant effect of diazoxide against dichlorvos-induced seizures in mice","volume":"2013","author":"Jazayeri","year":"2013","journal-title":"Sci World J"},{"key":"10.1016\/j.neuroscience.2019.11.020_b0135","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1016\/j.lfs.2003.11.007","article-title":"Propylparaben inhibits voltage-dependent sodium channels and protects cardiomyocytes from ischemia-reperfusion injury","volume":"74","author":"Ji","year":"2004","journal-title":"Life Sci"},{"key":"10.1016\/j.neuroscience.2019.11.020_b0140","doi-asserted-by":"crossref","first-page":"560","DOI":"10.3389\/fphar.2019.00560","article-title":"Enaminone modulators of extrasynaptic alpha4beta3delta gamma-aminobutyric acid A receptors reverse electrographic status epilepticus in the rat after acute organophosphorus poisoning","volume":"10","author":"Johnstone","year":"2019","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.neuroscience.2019.11.020_b0145","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0920-1211(02)00085-2","article-title":"Characterization of pharmacoresistance to benzodiazepines in the rat Li-pilocarpine model of status epilepticus","volume":"50","author":"Jones","year":"2002","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.neuroscience.2019.11.020_b0150","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.conb.2013.11.004","article-title":"GABA actions and ionic plasticity in epilepsy","volume":"26","author":"Kaila","year":"2014","journal-title":"Curr Opin Neurobiol"},{"key":"10.1016\/j.neuroscience.2019.11.020_b0155","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/ana.410380609","article-title":"Experimental status epilepticus alters gamma-aminobutyric acid type A receptor function in CA1 pyramidal neurons","volume":"38","author":"Kapur","year":"1995","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuroscience.2019.11.020_b0160","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.emc.2014.09.010","article-title":"Organophosphate and carbamate poisoning","volume":"33","author":"King","year":"2015","journal-title":"Emerg Med Clin North Am"},{"key":"10.1016\/j.neuroscience.2019.11.020_b0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2017.02.003","article-title":"A calpain inhibitor ameliorates seizure burden in an experimental model of temporal lobe epilepsy","volume":"102","author":"Lam","year":"2017","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neuroscience.2019.11.020_b0170","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.neuro.2016.09.019","article-title":"Propylparaben reduces the excitability of hippocampal neurons by blocking sodium channels","volume":"57","author":"Lara-Valderrabano","year":"2016","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuroscience.2019.11.020_b0175","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1152\/jn.91062.2008","article-title":"A simple quantitative method for analyzing electrographic status epilepticus in rats","volume":"101","author":"Lehmkuhle","year":"2009","journal-title":"J Neurophysiol"},{"key":"10.1016\/j.neuroscience.2019.11.020_b0180","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1056\/NEJM199804023381407","article-title":"Status epilepticus","volume":"338","author":"Lowenstein","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neuroscience.2019.11.020_b0185","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0006-8993(85)90324-5","article-title":"Protective effect of diazepam pretreatment on soman-induced brain lesion formation","volume":"325","author":"Martin","year":"1985","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2019.11.020_b0190","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/0002-9149(77)90164-3","article-title":"Intravenous diazoxide therapy in hypertensive crisis","volume":"40","author":"McDonald","year":"1977","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.neuroscience.2019.11.020_b0195","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0149-7634(96)00050-4","article-title":"Neuropharmacological mechanisms of nerve agent-induced seizure and neuropathology","volume":"21","author":"McDonough","year":"1997","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.neuroscience.2019.11.020_b0200","first-page":"381","article-title":"Neural lesions in the rat and their relationship to EEG delta activity following seizures induced by the nerve agent soman","volume":"19","author":"McDonough","year":"1998","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuroscience.2019.11.020_b0205","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3109\/01480540903483417","article-title":"Time-dependent reduction in the anticonvulsant effectiveness of diazepam against soman-induced seizures in guinea pigs","volume":"33","author":"McDonough","year":"2010","journal-title":"Drug Chem Toxicol"},{"key":"10.1016\/j.neuroscience.2019.11.020_b0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tox.2007.06.099","article-title":"Neuronal structures involved in the induction and propagation of seizures caused by nerve agents: implications for medical treatment","volume":"239","author":"Myhrer","year":"2007","journal-title":"Toxicology"},{"key":"10.1016\/j.neuroscience.2019.11.020_b0215","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/s11064-007-9429-3","article-title":"Anticonvulsant efficacy of drugs with cholinergic and\/or glutamatergic antagonism microinfused into area tempestas of rats exposed to soman","volume":"33","author":"Myhrer","year":"2008","journal-title":"Neurochem Res"},{"key":"10.1016\/j.neuroscience.2019.11.020_b0220","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.neuro.2018.02.009","article-title":"Development of neuropathology following soman poisoning and medical countermeasures","volume":"65","author":"Myhrer","year":"2018","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuroscience.2019.11.020_b0225","unstructured":"National Institute of Allergy and Infectious Disease (2016) Chemical Countermeasures Research Program. Retrieved July 26, 2019 from https:\/\/www.niaid.nih.gov\/research\/chemical-countermeasures-program."},{"key":"10.1016\/j.neuroscience.2019.11.020_b0230","unstructured":"National Institute of Allergy and Infectious Disease (2017) The NIH medical research program directed against chemical threats: 2017 report on research progress and future directions. Retrieved July 26, 2019 from https:\/\/www.niaid.nih.gov\/sites\/default\/files\/NIHChemicalPlan.pdf."},{"key":"10.1016\/j.neuroscience.2019.11.020_b0235","doi-asserted-by":"crossref","first-page":"7724","DOI":"10.1523\/JNEUROSCI.4944-04.2005","article-title":"Trafficking of GABA(A) receptors, loss of inhibition, and a mechanism for pharmacoresistance in status epilepticus","volume":"25","author":"Naylor","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2019.11.020_b0240","unstructured":"Ng E (2017, October 3) Post-mortem: VX poison killed brother of North Korean leader. Retrieved July 26, 2019 from https:\/\/apnews.com\/90e425dbaf1e44d1ba77e2eea890fc67."},{"key":"10.1016\/j.neuroscience.2019.11.020_b0245","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/1043-6618(94)80001-4","article-title":"Effects of chloroquine on pentylenetetrazol-induced convulsions in mice","volume":"30","author":"N'Gouemo","year":"1994","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.neuroscience.2019.11.020_b0250","first-page":"284","article-title":"Mouth breathing increases the pentylenetetrazole-induced seizure threshold in mice: a role for ATP-sensitive potassium channels","volume":"13","author":"Niaki","year":"2008","journal-title":"E&B"},{"key":"10.1016\/j.neuroscience.2019.11.020_b0255","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.bbrc.2016.04.105","article-title":"Anti-inflammatory activity of chloroquine and amodiaquine through p21-mediated suppression of T cell proliferation and Th1 cell differentiation","volume":"474","author":"Oh","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.neuroscience.2019.11.020_b0260","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0166-2236(03)00068-7","article-title":"Cation-chloride co-transporters in neuronal communication, development and trauma","volume":"26","author":"Payne","year":"2003","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.neuroscience.2019.11.020_b0265","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1901\/jeab.1994.61-319","article-title":"Neurology and neuropathology of soman-induced brain injury: an overview","volume":"61","author":"Petras","year":"1994","journal-title":"J Exp Anal Behav"},{"key":"10.1016\/j.neuroscience.2019.11.020_b0270","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.neuro.2016.08.002","article-title":"A rodent model of human organophosphate exposure producing status epilepticus and neuropathology","volume":"56","author":"Pouliot","year":"2016","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuroscience.2019.11.020_b0275","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S1474-4422(14)70303-5","article-title":"Bumetanide for the treatment of seizures in newborn babies with hypoxic ischaemic encephalopathy (NEMO): an open-label, dose finding, and feasibility phase 1\/2 trial","volume":"14","author":"Pressler","year":"2015","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neuroscience.2019.11.020_b0280","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/nyas.13160","article-title":"Neurosteroids for the potential protection of humans against organophosphate toxicity","volume":"1378","author":"Reddy","year":"2016","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.neuroscience.2019.11.020_b0285","series-title":"Presented at the 9th Annual NIH Countermeasures Against Chemical Threats Network Research Symposium. June 15-17, 2015. New York, NY","article-title":"Efficacy of neurosteroid therapy against soman-induced seizures and brain injury","author":"Reddy","year":"2015"},{"key":"10.1016\/j.neuroscience.2019.11.020_b0290","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0306-4522(99)00132-3","article-title":"N-methyl-D-aspartate receptor activation regulates refractoriness of status epilepticus to diazepam","volume":"93","author":"Rice","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2019.11.020_b0295","unstructured":"Robb EL, Baker MB (2019, March 2) Organophosphate Toxicity. In: StatPearls. Retrieved July 26, 2019 from https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK470430\/."},{"issue":"Suppl 6","key":"10.1016\/j.neuroscience.2019.11.020_b0300","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/epi.12289","article-title":"Neuroactive steroids for the treatment of status epilepticus","volume":"54","author":"Rogawski","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuroscience.2019.11.020_b0305","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.exer.2016.04.020","article-title":"ATP sensitive potassium channel openers: A new class of ocular hypotensive agents","volume":"158","author":"Roy Chowdhury","year":"2017","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.neuroscience.2019.11.020_b0310","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.neuro.2017.01.009","article-title":"Propylparaben applied after pilocarpine-induced status epilepticus modifies hippocampal excitability and glutamate release in rats","volume":"59","author":"Santana-Gomez","year":"2017","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuroscience.2019.11.020_b0315","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.neuint.2018.09.004","article-title":"Neuroprotective effects of levetiracetam, both alone and combined with propylparaben, in the long-term consequences induced by lithium-pilocarpine status epilepticus","volume":"120","author":"Santana-Gomez","year":"2018","journal-title":"Neurochem Int"},{"key":"10.1016\/j.neuroscience.2019.11.020_b0320","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1124\/jpet.118.252155","article-title":"Intravenously administered ganaxolone blocks diazepam-resistant lithium-pilocarpine-induced status epilepticus in rats: comparison with allopregnanolone","volume":"368","author":"Saporito","year":"2019","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuroscience.2019.11.020_b0325","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0006-8993(00)02513-0","article-title":"Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration","volume":"874","author":"Schmued","year":"2000","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2019.11.020_b0330","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0041-008X(03)00019-X","article-title":"Control of nerve agent-induced seizures is critical for neuroprotection and survival","volume":"188","author":"Shih","year":"2003","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.neuroscience.2019.11.020_b0335","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/(SICI)1099-1263(199707)17:4<255::AID-JAT441>3.0.CO;2-D","article-title":"Neurochemical mechanisms in soman-induced seizures","volume":"17","author":"Shih","year":"1997","journal-title":"J Appl Toxicol: JAT"},{"key":"10.1016\/j.neuroscience.2019.11.020_b0340","first-page":"86","article-title":"Anticonvulsants for soman-induced seizure activity","volume":"6","author":"Shih","year":"1999","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.neuroscience.2019.11.020_b0345","series-title":"Medical Aspects of Chemical and Biological Warfare","first-page":"129","article-title":"Nerve Agents","author":"Sidell","year":"1997"},{"key":"10.1016\/j.neuroscience.2019.11.020_b0350","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/epi.13270","article-title":"Bumetanide reduces seizure progression and the development of pharmacoresistant status epilepticus","volume":"57","author":"Sivakumaran","year":"2016","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuroscience.2019.11.020_b0355","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s12031-009-9253-0","article-title":"Protection against sarin-induced seizures in rats by direct brain microinjection of scopolamine, midazolam or MK-801","volume":"40","author":"Skovira","year":"2010","journal-title":"J Mol Neurosci: MN"},{"key":"10.1016\/j.neuroscience.2019.11.020_b0360","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.neuro.2012.03.006","article-title":"Neuropharmacological specificity of brain structures involved in soman-induced seizures","volume":"33","author":"Skovira","year":"2012","journal-title":"Neurotoxicology"},{"issue":"7","key":"10.1016\/j.neuroscience.2019.11.020_b0365","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1111\/epi.16050","article-title":"Antiseizure and neuroprotective effects of delayed treatment with midazolam in a rodent model of organophosphate exposure","volume":"60","author":"Spampanato","year":"2019","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuroscience.2019.11.020_b0370","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1007\/s004310050900","article-title":"Long-term treatment of persistent hyperinsulinaemic hypoglycaemia of infancy with diazoxide: a retrospective review of 77 cases and analysis of efficacy-predicting criteria","volume":"157","author":"Touati","year":"1998","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.neuroscience.2019.11.020_b0375","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1528-1157.1994.tb02908.x","article-title":"Determinants of mortality in status epilepticus","volume":"35","author":"Towne","year":"1994","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuroscience.2019.11.020_b0380","doi-asserted-by":"crossref","first-page":"781","DOI":"10.3332\/ecancer.2017.781","article-title":"Repurposing drugs in oncology (ReDO)-chloroquine and hydroxychloroquine as anti-cancer agents","volume":"11","author":"Verbaanderd","year":"2017","journal-title":"Ecancermedicalscience"},{"key":"10.1016\/j.neuroscience.2019.11.020_b0385","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0014-4886(88)90010-6","article-title":"Response of status epilepticus induced by lithium and pilocarpine to treatment with diazepam","volume":"101","author":"Walton","year":"1988","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neuroscience.2019.11.020_b0390","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jneumeth.2005.09.014","article-title":"Efficient unsupervised algorithms for the detection of seizures in continuous EEG recordings from rats after brain injury","volume":"152","author":"White","year":"2006","journal-title":"J Neurosci Methods"},{"key":"10.1016\/j.neuroscience.2019.11.020_b0395","unstructured":"World Health Organization (WHO) (2018, August 24) Suicide. Retrieved July 26, 2019 from https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/suicide."},{"key":"10.1016\/j.neuroscience.2019.11.020_b0400","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1124\/jpet.117.247106","article-title":"Midazolam-resistant seizures and brain injury after acute intoxication of diisopropylfluorophosphate, an organophosphate pesticide and durrogate for nerve agents","volume":"367","author":"Wu","year":"2018","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuroscience.2019.11.020_b0405","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jns.2006.06.007","article-title":"Sarin experiences in Japan: acute toxicity and long-term effects","volume":"249","author":"Yanagisawa","year":"2006","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neuroscience.2019.11.020_b0410","series-title":"Chemical Warfare Agents: Biomedical and Psychological Effects, Medical Countermeasures, and Emergency Response","first-page":"615","article-title":"An Overview of the NIAID\/NIH Chemical Medical Countermeasures Product Research and Development Program","author":"Yeung","year":"2019"},{"key":"10.1016\/j.neuroscience.2019.11.020_b0415","unstructured":"Yeung D (2019) CounterACT neurotherapeutic screening (CNS) program. Retrieved July 26, 2019 from https:\/\/www.ninds.nih.gov\/sites\/default\/files\/CNS_program_0.pdf."},{"issue":"Suppl 2","key":"10.1016\/j.neuroscience.2019.11.020_b0420","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/epi.13999","article-title":"Intramuscular allopregnanolone and ganaxolone in a mouse model of treatment-resistant status epilepticus","volume":"59","author":"Zolkowska","year":"2018","journal-title":"Epilepsia"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452219307961?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452219307961?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T15:55:18Z","timestamp":1759679718000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452219307961"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":84,"alternative-id":["S0306452219307961"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2019.11.020","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Screening for Efficacious Anticonvulsants and Neuroprotectants in Delayed Treatment Models of Organophosphate-induced Status Epilepticus","name":"articletitle","label":"Article Title"},{"value":"Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuroscience.2019.11.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 IBRO. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}